ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Davidboon
|
1.3K |
555K |
4 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Davidboon
|
1.3K |
555K |
8 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
Davidboon
|
211 |
73K |
31 |
03/01/22 |
03/01/22 |
ASX - By Stock
|
211
|
73K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
Davidboon
|
211 |
73K |
31 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
211
|
73K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
Davidboon
|
1.0K |
419K |
12 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
1.0K
|
419K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
8 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
344
|
100K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
15 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
344
|
100K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
Davidboon
|
516 |
156K |
14 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
516
|
156K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Davidboon
|
76 |
15K |
5 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
76
|
15K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Davidboon
|
76 |
15K |
3 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
76
|
15K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Davidboon
|
76 |
15K |
1 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
76
|
15K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Davidboon
|
76 |
15K |
7 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
76
|
15K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Davidboon
|
76 |
15K |
19 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
76
|
15K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
Davidboon
|
158 |
46K |
12 |
21/08/21 |
21/08/21 |
ASX - By Stock
|
158
|
46K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
18 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
344
|
100K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
Davidboon
|
340 |
113K |
13 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
340
|
113K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
26 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
344
|
100K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
9 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
344
|
100K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
16 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
344
|
100K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
Davidboon
|
158 |
46K |
7 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
158
|
46K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
Davidboon
|
158 |
46K |
9 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
158
|
46K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
13 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
344
|
100K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Davidboon
|
4.7K |
1.1M |
20 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Davidboon
|
4.7K |
1.1M |
24 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
12 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
344
|
100K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
25 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
344
|
100K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
9 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
344
|
100K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
3 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
344
|
100K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
12 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
344
|
100K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
25 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
344
|
100K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
7 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
344
|
100K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
51 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
344
|
100K
|
51
|
|
ASX - By Stock
|
MSB |
Growing Confidence on COVID-19 Application
|
|
Davidboon
|
344 |
100K |
96 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
344
|
100K
|
96
|
|
ASX - By Stock
|
MSB |
Re:
Why has Novartis taken down the MSB media release from their website?
|
|
Davidboon
|
28 |
11K |
36 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
28
|
11K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Davidboon
|
17K |
6.8M |
37 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
17K
|
6.8M
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Management Update
|
|
Davidboon
|
157 |
46K |
20 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
157
|
46K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Management Update
|
|
Davidboon
|
157 |
46K |
12 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
157
|
46K
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Davidboon
|
10K |
3.0M |
5 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Davidboon
|
10K |
3.0M |
41 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
41
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Davidboon
|
17K |
6.8M |
11 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
17K
|
6.8M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Davidboon
|
281 |
77K |
15 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
281
|
77K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Davidboon
|
281 |
77K |
10 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
281
|
77K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Davidboon
|
281 |
77K |
16 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
281
|
77K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Davidboon
|
17K |
6.8M |
42 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
17K
|
6.8M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Davidboon
|
17K |
6.8M |
9 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
17K
|
6.8M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Davidboon
|
281 |
77K |
41 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
281
|
77K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Davidboon
|
281 |
77K |
23 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
281
|
77K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT
|
|
Davidboon
|
251 |
91K |
18 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
251
|
91K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT
|
|
Davidboon
|
251 |
91K |
54 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
251
|
91K
|
54
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT
|
|
Davidboon
|
251 |
91K |
22 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
251
|
91K
|
22
|
|